Patent application number | Description | Published |
20090000484 | CONDITIONING SYSTEM AND METHOD FOR USE IN THE MEASUREMENT OF MERCURY IN GASEOUS EMISSIONS - Embodiments of the invention relate generally to systems used to measure mercury in gaseous emissions. In one aspect, the invention is directed to the use of silicon carbide as material for a thermal pyrolysis unit. In another aspect, at least one of silicon nitride, silicon boride, and/or boron nitride is used as material for a thermal pyrolysis unit. In another aspect, the invention is directed to an improved pyrolyzer design, in which a thermal pyrolysis unit comprises a tailpiece that allows water to be injected at the heated exit of the thermal pyrolysis unit. In another aspect, the invention is directed to the use of a coalescing filter in a scrubbing unit. In another aspect, the invention is directed to the use of a hydrophobic filter element in a scrubbing unit. One or more of these elements may be used in a conditioning module of a continuous emissions monitoring system, for example. | 01-01-2009 |
20090011512 | CONDITIONING SYSTEM AND METHOD FOR USE IN THE MEASUREMENT OF MERCURY IN GASEOUS EMISSIONS - Embodiments of the invention relate generally to systems used to measure mercury in gaseous emissions. In one aspect, the invention is directed to the use of silicon carbide as material for a thermal pyrolysis unit. In another aspect, at least one of silicon nitride, silicon boride, and/or boron nitride is used as material for a thermal pyrolysis unit. In another aspect, the invention is directed to an improved pyrolyzer design, in which a thermal pyrolysis unit comprises a tailpiece that allows water to be injected at the heated exit of the thermal pyrolysis unit. In another aspect, the invention is directed to the use of a coalescing filter in a scrubbing unit. In another aspect, the invention is directed to the use of a hydrophobic filter element in a scrubbing unit. One or more of these elements may be used in a conditioning module of a continuous emissions monitoring system, for example. | 01-08-2009 |
Patent application number | Description | Published |
20110023815 | Crank Joint Linked Radial and Circumferential Oscillating Rotating Piston Device - Axially protruding and centrally cool able pistons rotate within a cylindrical main chamber. Each piston is individually kinetically linked to a flywheel. As the pistons are individually accelerated and decelerated along their continuous rotating path, rotating volumes between them angularly expand and contract. Inlets and outlets communicate fluid in correspondence with expansion and contraction phases of the rotating volumes. A low number of moving parts, area sealed volumes, no valves, balanced mass forces, smooth rotation and short force transmission paths between opposing mass forces provide for lightweight construction and high rotational speeds. Radial sliding secondary pistons of the kinetic linkage modulate secondary rotating volumes adjacent the main chamber for a dual stage thermodynamically efficient engine operation with intermittent fluid cooling or heating. Inlets and/or outlets may be angularly changed for variable compression and/or combustion engine peak pressures, expansion end pressure, for brake energy recycling and burst mode engine operation. | 02-03-2011 |
20110027113 | Crank Joint Linked Radial and Circumferential Oscillating Rotating Piston Device - Axially protruding, centrally cooled pistons rotate around a stationary rotation axis within a cylindrical main chamber. Hinged to each piston is a slider in a radial guide that is steadily rotating around another offset stationary rotation axis. As the pistons are individually accelerated and decelerated via the guides, sliders and hinges, rotating volumes between them angularly expand and contract. Inlets and outlets communicate fluid in correspondence with expansion and contraction phases of the rotating volumes. A low number of moving parts, area sealed volumes, no valves, substantially no dead volume, balanced mass forces, smooth rotation and short force transmission paths between opposing mass forces provide for lightweight construction and high rotational speeds. The sliders may be secondary pistons radial modulating secondary rotating volumes adjacent the main chamber for a dual stage thermodynamically efficient operation with intermittent fluid cooling or heating. | 02-03-2011 |
Patent application number | Description | Published |
20090199917 | Microfluidic Device with Variable Volume Material - The invention relates to a microfluidic device comprising a first plate forming the substrate and including at least one perforation and, on either side of said first plate, at several locations, a material for defining passage portions consisting, in at least one of said locations, of an activatable material varying in volume on activation, said material being disposed at said locations in an arrangement that, during a first phase and upon activation of at least one location consisting of said activatable material, transforms it from a first configuration to a second configuration, modifying a three-dimensional network corresponding, in the second configuration and depending on the selected location(s) that are activated in said first phase, to different liquid paths including passage portions in offset planes parallel to the plane of the first plate, at least on either side of said first plate, and between which at least one of said perforations is located. | 08-13-2009 |
20100028170 | Device for Delivering a Liquid, the Device Comprising a Pump and a Valve - The invention relates to a device for delivering a liquid, which device comprises a pump, and an anti-siphon valve external to the pump and having an inlet channel connected to the outlet duct of the pump, and an outlet channel, between which channels a seat and a moving member are disposed that are suitable for co-operating together and that define, between the inlet channel and the outlet channel, a leaktight liquid flow zone, said moving member being suitable for going from an opening position making it possible for liquid to flow through said flow zone, to a closure position in which the moving member comes into contact with the seat of the valve and prevents any flow through said flow zone, said moving member being subjected to the pressure of a reference chamber that is not in fluid communication with the outlet channel. Application to obtaining a pump for injecting liquid medication. | 02-04-2010 |
Patent application number | Description | Published |
20150027613 | ELECTROCHROMIC FILMS AND RELATED METHODS THEREOF - EC film stacks and different layers within the EC film stacks are disclosed. Methods of manufacturing these layers are also disclosed. In one embodiment, an EC layer comprises nanostructured EC layer. These layers may be manufactured by various methods, including, including, but not limited to glancing, angle deposition, oblique angle deposition, electrophoresis, electrolyte deposition, and atomic layer deposition. The nanostructured EC layers have a high specific surface area, improved response times, and higher color efficiency. | 01-29-2015 |
20150297886 | IMPLANTABLE MEDICAL LEADS, SYSTEMS, AND RELATED METHODS FOR CREATING A HIGH IMPEDANCE WITHIN A CONDUCTION PATH IN THE PRESENCE OF A MAGNETIC FIELD OF A GIVEN STRENGTH - Implantable medical systems include implantable medical leads that have magnetic orientation-independent magnetically actuated switches that are placed in the conduction path to the electrode of the lead. Thus, regardless of the orientation of a substantial magnetic field like that from an MRI machine to the lead and switch within the lead, the switch opens when in the presence of that substantial magnetic field. The switch may be placed in close proximity to the electrode such that the opening of the switch disconnects the electrode from the majority of the conduction path which thereby produces a high impedance for RF current and reduces the amount of heating that may occur at the electrode when in the presence of substantial levels of RF electromagnetic energy as may occur within an MRI machine. | 10-22-2015 |
Patent application number | Description | Published |
20090010820 | Micro-Fluidic System - In one aspect, a micro-fluidic system consisting of modules that are arranged side by side in a row, each module containing a micro-fluidic unit and an associated electric control unit is provided. The rear faces of the modules lie against a common vertical rear wall unit and are held against the unit. In the modules, the respective control unit is located in the vicinity of the rear face and the micro-fluidic unit is situated in a region that is remote from the rear face. The control units can be connected to an electric line bus that runs through the rear wall unit via electric connectors that are located on the rear faces of the modules and on the rear wall unit and the micro-fluidic units of two respective neighboring modules are interconnected to allow the passage of fluid via a connecting part that contains connection channels and that spans the relevant modules. | 01-08-2009 |
20090126504 | Microfluidic System - The microfluidic system is constituted of modules that comprise one microfluidic unit and one corresponding electric control unit each and that are retained on a rear panel unit next to each other in a row. To prevent the formation of accumulation of ignitable or toxic gas mixtures a fluid conduit for a rinsing fluid extends through the rear panel unit. Branches lead from said fluid conduit to the modules, and said branches flowing into respective distributor compartments that extend vertically across the module height in the modules. Said distributor compartments are delimited in relation to the interior of the respective module by a distributor panel that is provide with openings. The interior of the respective module comprises, on its lower or rear surface, an exit opening for the rinsing fluid. | 05-21-2009 |
20100021345 | Modular Microfluidic System - There is described a modular microfluidic system with the following features: Modules are arranged next to each other in a row. Every module has a microfluidic part which rests on a contact surface of the module in a locally limited area and is forced against the same by means of a fastening element. The microfluidic part comprises a fluid channel system with fluid connections that are arranged on the top surface of the microfluidic part in edge areas relative to the adjoining microfluidic parts. The fluid connections of adjoining microfluidic parts are interlinked by respective connecting channels in a connecting part bridging the microfluidic parts, said connecting part resting on the microfluidic parts in the edge areas. A clamping part rests against the lower surfaces of the adjoining microfluidic parts and is connected to the connecting part via an additional fastening element in the area between the microfluidic parts. | 01-28-2010 |
20100247380 | Module for a Modular Microfluidic System - In order to be able to introduce fluid components extraneous to the system into a modular microfluidic system comprising modules arranged alongside one another which can be connected to one another with fluid connection by connecting parts comprising connecting channels with short connecting paths and good temperature controllability, a module with the following features is provided: the module has a plate-shaped microfluidic part which comprises a fluid channel system and on whose top side, in edge regions to the potentially adjacent modules of the microfluidic system has fluid connections, the fluidic connection to adjacent modules being establishable by means of the connecting parts adjacent in edge regions on the upper side, below the microfluidic part is arranged an insulation vessel which can be filled and flowed through by a temperature control fluid and is concluded at the to by the microfluidic part which serves as a lid. | 09-30-2010 |
Patent application number | Description | Published |
20080299190 | Direct Compression Formulation and Process - This invention relates to tablets especially tablets formed by direct compression of a dipeptidylpeptidase IV (DPP-IV) inhibitor compound, a process for the preparation thereof; to new pharmaceutical formulations, and new tableting powders comprising DPP-IV inhibitor formulations capable of being directly compressed into tablets. The invention relates further to a process for preparing the tablets by blending the active ingredient and specific excipients into the new formulations and then directly compressing the formulations into the direct compression tablets. The invention also relates to vildagliptin particle size distribution and a new crystal form of vildagliptin particularly adapted for the preparation of improved tablets and other pharmaceutical compositions. | 12-04-2008 |
20120015029 | DIRECT COMPRESSION FORMULATION AND PROCESS - This invention relates to tablets especially tablets formed by direct compression of a dipeptidylpeptidase IV (DPP-IV) inhibitor compound, a process for the preparation thereof, to new pharmaceutical formulations, and new tableting powders comprising DPP-IV inhibitor formulations capable of being directly compressed into tablets. The invention relates further to a process for preparing the tablets by blending the active ingredient and specific excipients into the new formulations and then directly compressing the formulations into the direct compression tablets. The invention also relates to vildagliptin particle size distribution and a new crystal form of vildagliptin particularly adapted for the preparation of improved tablets and other pharmaceutical compositions. | 01-19-2012 |
20120115840 | HEMIFUMARATE SALT OF 1-[4-[1-(4-CYCLOHEXYL-3-TRIFLUOROMETHYL-BENZYLOXYIMINO)-ETHYL]-2-ETHYL-BE- NZYL]-AZETIDINE-3-CARBOXYLIC ACID - This invention relates to a hemifumarate salt of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid (Compound I), to pharmaceutical compositions comprising this salt, to processes for forming this salt and to its use in medical treatment. In addition, the present invention also relates to new polymorphic forms of the hemifumarate salt form of Compound I, as well as to pharmaceutical compositions comprising these polymorphic forms, to processes for obtaining them, and their use in medical treatment. | 05-10-2012 |
20130137737 | HIGHLY CRYSTALLINE VALSARTAN - The present invention describes a highly crystalline form of valsartan, pharmaceutical compositions thereof and process for the preparation thereof. | 05-30-2013 |
20140005162 | HEMIFUMARATE SALT OF 1-[4-[1-(4-CYCLOHEXYL-3-TRIFLUOROMETHYL-BENZYLOXYIMINO)-ETHYL]-2-ETHYL-BE- NZYL]-AZETIDINE-3-CARBOXYLIC ACID | 01-02-2014 |
20150175536 | HEMIFUMARATE SALT OF 1-[4-[1-(4-CYCLOHEXYL-3-TRIFLUOROMETHYL-BENZYLOXYIMINO)-ETHYL]-2-ETHYL-BE- NZYL]-AZETIDINE-3-CARBOXYLIC ACID - This invention relates to a hemifumarate salt of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid (Compound I), to pharmaceutical compositions comprising this salt, to processes for forming this salt and to its use in medical treatment. In addition, the present invention also relates to new polymorphic forms of the hemifumarate salt form of Compound I, as well as to pharmaceutical compositions comprising these polymorphic forms, to processes for obtaining them, and their use in medical treatment. | 06-25-2015 |
Patent application number | Description | Published |
20110191912 | Promoter, promoter control elements, and combinations, and uses thereof - The present invention provides DNA molecules that constitute fragments of the genome of a plant, and polypeptides encoded thereby. The DNA molecules are useful for specifying a gene product in cells, either as a promoter or as a protein coding sequence or as an UTR or as a 3′ termination sequence, and are also useful in controlling the behavior of a gene in the chromosome, in controlling the expression of a gene or as tools for genetic mapping, recognizing or isolating identical or related DNA fragments, or identification of a particular individual organism, or for clustering of a group of organisms with a common trait. One of ordinary skill in the art, having this data, can obtain cloned DNA fragments, synthetic DNA fragments or polypeptides constituting desired sequences by recombinant methodology known in the art or described herein. | 08-04-2011 |
20150033417 | Promoter, promoter control elements, and combinations, and uses thereof - The present invention provides DNA molecules that constitute fragments of the genome of a plant, and polypeptides encoded thereby. The DNA molecules are useful for specifying a gene product in cells, either as a promoter or as a protein coding sequence or as an UTR or as a 3′ termination sequence, and are also useful in controlling the behavior of a gene in the chromosome, in controlling the expression of a gene or as tools for genetic mapping, recognizing or isolating identical or related DNA fragments, or identification of a particular individual organism, or for clustering of a group of organisms with a common trait. One of ordinary skill in the art, having this data, can obtain cloned DNA fragments, synthetic DNA fragments or polypeptides constituting desired sequences by recombinant methodology known in the art or described herein. | 01-29-2015 |